OnCore Login
network member

Fox Chase Cancer Center

333 Cottman Avenue, Philadelphia, PA 19111
fox-chase

About Network Member

Website: Fox Chase Cancer Center
fox-chase
https://www.foxchase.org
Michael Oldfield
215-214-3769
Currently Enrolling

HCRN-GU22-598

Phase 2 trial of enfortumab vedotin plus pembrolizumab with selective bladder sparing for treatment of muscle-invasive urothelial cancer of the bladder
Cancer areas:Bladder
Fox Chase Cancer Center
Icahn School of Medicine at Mount Sinai
Learn More
See clinicaltrials.gov
Currently Enrolling

HCRN-GU16-243

PhAse I/II StuDy of Modern ImmunotherApy in BCG-RelaPsing UroThelial Carcinoma of the BLADDER – (ADAPT-BLADDER) HCRN GU16-243
Noah M. Hahn
Cancer areas:BladderUrothelial Carcinoma
Columbia University Irving Medical Center
Fox Chase Cancer Center
Fred & Pamela Buffett Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
University of Iowa Holden Comprehensive Cancer Center
Learn More
See clinicaltrials.gov
Enrollment Closed

HCRN-MEL16-252

Single Arm Phase II Study of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma (SALVO Study). HCRN: MEL16-252
Robert R. McWilliams
Cancer areas:Melanoma
Fox Chase Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Nebraska Cancer Specialists
Providence Cancer Institute
University of Iowa Holden Comprehensive Cancer Center
Learn More
See clinicaltrials.gov